Treatment of Hiccups
For intractable hiccups lasting more than 48 hours, chlorpromazine 25-50 mg three to four times daily is the FDA-approved first-line pharmacological treatment, though metoclopramide and baclofen are recommended as alternatives by major medical societies. 1
Initial Management Approach
Acute Hiccups (< 48 hours)
Start with simple physical maneuvers before considering pharmacotherapy, as most acute episodes resolve spontaneously within minutes. 2
- Apply pressure between the posterior border of the mandible and mastoid process (similar to Larson's maneuver) to terminate hiccups 3
- Stimulate the uvula or pharynx, or disrupt diaphragmatic respiratory rhythm 4
- These non-pharmacological measures are simple and often effective for benign, self-limited hiccups 4
Identify and Treat Underlying Causes
Before initiating empiric therapy, evaluate for treatable causes as hiccups may indicate serious underlying pathology. 2
Gastrointestinal causes (most common):
- If gastroesophageal reflux disease (GERD) is suspected, initiate high-dose proton pump inhibitor (PPI) therapy with response time variable from 2 weeks to several months 5
- Add prokinetic therapy such as metoclopramide if partial or no improvement occurs with PPI alone 5
- Implement antireflux diet and lifestyle modifications concurrently 5
- Consider 24-hour esophageal pH monitoring if empiric therapy is unsuccessful 5
Cardiovascular/thoracic causes:
- Hiccups with other local compression symptoms suggest pericardial effusion compressing the phrenic nerve 5
- Obtain chest X-ray and echocardiography if pericardial or thoracic pathology is suspected 5
Central nervous system causes:
- Brain tumors and traumatic brain injury can cause hiccups 5
- Consider neuroimaging in persistent cases without clear peripheral etiology 6
Pharmacological Treatment for Persistent/Intractable Hiccups
First-Line Agent
Chlorpromazine is the only FDA-approved medication specifically indicated for intractable hiccups. 1
- Dosing: 25-50 mg three to four times daily orally 1
- If symptoms persist for 2-3 days on oral therapy, parenteral administration is indicated 1
- Critical warning: Chlorpromazine can cause hypotension, sedation, extrapyramidal symptoms, and QT interval prolongation 5
- Use lower doses in elderly, emaciated, or debilitated patients who are more susceptible to hypotension and neuromuscular reactions 1
Second-Line Agents
Metoclopramide is recommended as a second-line agent by the American Society of Clinical Oncology based on randomized controlled trial evidence. 5
- Consider metoclopramide as an alternative, particularly when GERD is suspected as the underlying cause 5
- Can be used as add-on therapy to PPI if partial response occurs 5
Baclofen is the treatment of choice when simple physical maneuvers and causal therapy fail or are impossible. 7
- Baclofen acts on the reflex arc and has demonstrated efficacy in stepwise management plans 7
Other Pharmacological Options
Additional agents with reported efficacy include: 6
Special Situations
Perioperative/Anesthesia-Related Hiccups
For hiccups occurring during anesthesia or post-extubation, propofol 1-2 mg/kg IV may be effective. 3
- In severe cases associated with laryngospasm, follow the laryngospasm treatment algorithm including positive pressure ventilation with 100% oxygen 3
- Avoid airway stimulation which can worsen the condition 3
Non-Pharmacological Interventions for Refractory Cases
When pharmacotherapy fails: 6
- Nerve blockade (phrenic nerve) 6
- Pacing 6
- Acupuncture 6
- Interruption of the reflex arc may be considered as a last resort 7
Critical Pitfalls to Avoid
Do not dismiss persistent hiccups as benign without proper evaluation, as they can indicate serious underlying pathology. 2
- Untreated persistent hiccups can lead to weight loss and depression 5
- In tracheotomized patients, hiccups may cause alkalosis due to hyperventilation 7
- The respiratory effect is generally negligible in most patients 7
Do not delay treatment escalation in persistent cases, as prolonged hiccups can significantly impair quality of life. 5, 2